For licensed medical professionals and compounding pharmacies only. Not for sale to the general public.  ·  787-822-8197
Build Your Order Apply for Wholesale
Build Your Order Products For Clinics For Pharmacies For Brands Quality Wholesale Resources About Contact Apply for Wholesale
Product sourcing reference

Ipamorelin Sourcing Review

Ipamorelin review should address the ingredient form and any combination being proposed, without assuming a lawful clinical supply channel.

Reference variants

Add Ipamorelin to an order request

Quantities are individual vials (packs of 10). Orders need 100 vials and/or 20 spray bottles in total, mixed across items. Prices are reference estimates captured 2026-10-16; every request is pending eligibility and availability review. Per-unit figures are rounded to the cent from kit pricing, so a final quote may differ slightly.

  • 10mgVial · confirm physical formCAS 170851-70-4
    $16.04/vial$12.84/vial at 1,000+ vials of this item
    vials, packs of 10

Review your order request · Compare the full catalog

Keep single-ingredient and combination proposals separate

Record whether the request concerns ipamorelin alone or a combination. Evidence or documentation for one ingredient does not substantiate the safety or eligibility of a blend.

Confirm identity across every document

Check that the substance form named in the quote matches the label and analytical documentation. Do not compare prices until the specifications describe the same material.

Before a sourcing inquiry

For Ipamorelin, provide the exact substance or finished-product identity, intended transaction, facility type and destination state. Do not send patient information. A qualified reviewer must confirm the applicable pathway before purchasing.

  • Obtain product- and lot-specific identity and quality records before accepting material.
  • Verify storage, shipping and dating against the actual preparation, not a generic catalog range.
  • Request written confirmation of availability and terms; this page does not confirm stock, strength, price or supply eligibility.

We do not currently have verified COAs available to publish. No purity, sterility or lot-release result is established by this page.

Purchasing questions

Does a combination with CJC-1295 inherit an established pathway?

No. Each substance and the exact preparation require review. Marketing a combination does not establish approval, efficacy or permission to compound it.

Related sourcing guidance

Identify the salt and proposed route

FDA describes route-specific safety information gaps and characterization concerns for ipamorelin acetate. Evidence about one route cannot establish suitability for another preparation.

Documentation to request

Obtain the exact salt, identity methods and intended formulation; keep an ipamorelin-only proposal separate from a multi-peptide blend.

Regulatory context: FDA: substance-specific safety concerns. Source reviewed . This source does not verify the identity, testing or availability of our catalog references.

Related guidance: Hormone clinic purchasing review. These references support a review, not a treatment recommendation or supply authorization.

Verify the current regulatory position

Use FDA human drug compounding guidance and applicable state requirements. A compounded preparation is not FDA-approved. This reference is not medical or legal advice and does not establish a lawful supply route.

Ask about the review requirements

Ask what information is needed to assess a Ipamorelin inquiry. An inquiry is not confirmation that the product can be supplied.

Discuss sourcing requirements
Call Apply for Wholesale